Eton Pharmaceuticals, Inc. (ETON)
63.05
-1.38
(-2.14%)
USD |
NASDAQ |
Aug 25, 16:00
63.60
+0.55
(+0.87%)
After-Hours: 05:38
Eton Pharmaceuticals 1 Year Total Returns (Daily) : 268.9% for Aug. 25, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 25, 2026 | 268.9% |
| August 24, 2026 | 272.4% |
| August 21, 2026 | 271.4% |
| August 20, 2026 | 262.0% |
| August 19, 2026 | 279.5% |
| August 18, 2026 | 287.5% |
| August 17, 2026 | 262.3% |
| August 14, 2026 | 252.5% |
| August 13, 2026 | 138.3% |
| August 12, 2026 | 140.1% |
| August 11, 2026 | 146.6% |
| August 10, 2026 | 154.8% |
| August 07, 2026 | 192.3% |
| August 06, 2026 | 202.6% |
| August 05, 2026 | 212.1% |
| August 04, 2026 | 218.5% |
| August 03, 2026 | 219.5% |
| July 31, 2026 | 227.8% |
| July 30, 2026 | 237.7% |
| July 29, 2026 | 233.5% |
| July 28, 2026 | 210.4% |
| July 27, 2026 | 174.7% |
| July 24, 2026 | 177.1% |
| July 23, 2026 | 188.7% |
| July 22, 2026 | 198.7% |
| Date | Value |
|---|---|
| July 21, 2026 | 200.0% |
| July 20, 2026 | 173.4% |
| July 17, 2026 | 203.4% |
| July 16, 2026 | 167.7% |
| July 15, 2026 | 166.8% |
| July 14, 2026 | 158.0% |
| July 13, 2026 | 157.7% |
| July 10, 2026 | 135.3% |
| July 09, 2026 | 136.7% |
| July 08, 2026 | 128.9% |
| July 07, 2026 | 162.3% |
| July 06, 2026 | 163.1% |
| July 02, 2026 | 159.0% |
| July 01, 2026 | 161.5% |
| June 30, 2026 | 154.0% |
| June 29, 2026 | 162.2% |
| June 26, 2026 | 155.7% |
| June 25, 2026 | 157.9% |
| June 24, 2026 | 150.0% |
| June 23, 2026 | 147.9% |
| June 22, 2026 | 141.1% |
| June 18, 2026 | 137.1% |
| June 17, 2026 | 140.7% |
| June 16, 2026 | 128.3% |
| June 15, 2026 | 124.8% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Nektar Therapeutics | 176.2% |
| Pfizer Inc. | 21.65% |
| Elite Pharmaceuticals, Inc. | -48.46% |
| Daré Bioscience, Inc. | -60.54% |
| Liquidia Corp. | 168.5% |